about
Primary growth hormone insensitivity (Laron syndrome) and acquired hypothyroidism: a case reportUse of Pegvisomant in acromegaly. An Italian Society of Endocrinology guidelineOccult leydig cell tumour and androgen-receptor positive breast cancer in a woman with severe hyperandrogenism.Chronic idiopathic urticaria and Graves' disease.HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies.Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.Cardiovascular outcomes and conventional risk factors in non-diabetic adult patients with GH deficiency: A long-term retrospective cohort study.Coexistence of growth hormone-secreting pituitary adenoma and intracranial meningioma: a case report and review of the literature.Does pegvisomant treatment expertise improve control of resistant acromegaly? The Italian ACROSTUDY experience.Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study.Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism.MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case.Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma.MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients.Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.Confirmation of local amino acid sequence homology between human prolactin and the amyloid-related proteins.High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.Effectiveness of long-term rosiglitazone administration in patients with Cushing's disease.Clinical presentation and outcome of pituitary adenomas in teenagers.Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients.Spontaneous intermittent MRI changes of a pituitary stalk lesion causing diabetes insipidus and amenorrhea.Pregnancy after azathioprine therapy for ulcerative colitis in a woman with autoimmune premature ovarian failure and Addison's disease: HLA haplotype characterization.Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy.A 53-year-old woman with Cushing's disease and a pituitary tumor.Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography.Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry.Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review.Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report.Aryl hydrocarbon receptor interacting protein(AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomasSevere head trauma in patients with unexplained central hypothyroidismACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed diseaseAnalysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).Abnormal daily periodicity of serum thyrotropin (TSH) and evidence for defective TSH suppression in a case of non-neoplastic syndrome of inappropriate TSH secretionAbnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during the spontaneous remission of Cushing's diseaseEchocardiographic evaluation in acromegalic patientsEarly-onset cerebellar ataxia, myoclonus and hypogonadism in a case of mitochondrial complex III deficiency treated with vitamins K3 and C
P50
Q21202087-3704033F-3482-43DB-B295-A1710ECA8D51Q34277844-6DCBCBC8-FEA8-4C5D-9790-8C1A0D1FF691Q36988229-DD1236E3-43DB-4FEA-ADD5-E4222F7326F1Q38101011-E7BDBCEA-105A-4950-8AB0-DA302BD91A51Q38397298-2A6701A5-5EC6-4F58-8EF2-CA32FA1B3537Q38650974-765E0055-C024-4B25-887D-9C0D6AC93925Q39104763-02D28B0F-BBF0-490A-96FD-D258397C5ACAQ40343967-3DBA88AE-EBCC-466C-AC49-B77F4153C7E4Q40802038-E22B66C3-C18D-41CE-8442-B2E510195A24Q41009206-2A5B4A83-F5ED-4EFC-925A-9D67AB416C31Q41069104-EFF9B095-FC59-40B9-A43F-50E9BC2FB4A2Q41488000-D54A193C-83C1-4FA9-8438-3017051FDF44Q42465771-5BAED4D0-73EE-4743-A466-3E6848263B88Q42480377-0B2696DA-EE80-4109-BF24-AC6E3FDA4D2DQ42509128-4DD55F6C-1A20-41C2-96FA-88CC52C64284Q43770850-EB60063F-34E5-46B5-9286-656161A8D9D4Q43854943-E503796B-C4B0-4260-9D77-F3B8A70DACC6Q44565167-A33A9716-AE2F-4544-A032-77D55C3C68EFQ45759393-B4D35189-1218-4860-8CF3-64A197356999Q45998725-80E0ADE8-6898-4216-B730-B74A5D6D92A5Q46552841-FD328ED4-E2A8-4913-A45C-1C2E56B30996Q48029885-A6B949EB-DAD5-47A7-9B94-7BE273D441C9Q48265197-E3F9A9DC-D1B1-44A1-9AC5-69E451A6CF7AQ48341573-7DF8B44C-AE2C-4B00-BDF9-8FA348E4CD48Q51052214-09761B6A-17CC-48E5-ABD7-8E7DE965A513Q51382411-B529B7AE-B04A-4803-ACBA-796AB7B01162Q51704591-6B3A704A-F9EF-45B4-918E-FB67708741ACQ51937881-D70088FD-597B-4FAC-ACB5-227B2CD26C15Q53450362-1479DD03-F3AE-42CA-8542-50C6C63CA830Q53799921-28A26F56-E1CE-465D-A26B-6A59644F17AEQ55024337-A09609A6-9EA4-4C3C-B392-9C7BFA892574Q55234411-EADBF9F4-97D2-40B0-BCDF-7CBB886FA6D6Q57567527-C6BD00DE-0D4B-427B-BBC1-E13254C2DDDCQ57951085-A79C9E48-46A0-499A-97B1-EBA71595C664Q60674283-3CBB0228-F78C-49F3-B667-F09F52D63FE4Q64976872-4E392C55-D4A5-4F5F-9B14-AFF6BB72BDCEQ69027252-459A4F2C-E628-446B-9E6B-026481E3351DQ69846459-887322C8-74C9-4B2B-85ED-9B5C4A67EEA7Q70069199-BEEF3D68-FE0C-4D71-94D7-77244C73C0F7Q72351955-2BCA84B6-F999-4619-BFD9-D05779BDD584
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Salvatore Cannavo
@ast
Salvatore Cannavo
@en
Salvatore Cannavo
@es
Salvatore Cannavo
@nl
type
label
Salvatore Cannavo
@ast
Salvatore Cannavo
@en
Salvatore Cannavo
@es
Salvatore Cannavo
@nl
prefLabel
Salvatore Cannavo
@ast
Salvatore Cannavo
@en
Salvatore Cannavo
@es
Salvatore Cannavo
@nl
P1153
22955678000
P31
P496
0000-0001-8779-7283